StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report released on Saturday. The firm issued a hold rating on the stock.

Separately, Benchmark initiated coverage on shares of Milestone Scientific in a research note on Thursday, October 10th. They issued a “speculative buy” rating and a $1.25 price objective for the company.

Milestone Scientific Stock Performance

MLSS stock opened at $0.79 on Friday. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10. The company has a fifty day moving average of $0.91 and a 200-day moving average of $0.83. The stock has a market capitalization of $61.11 million, a PE ratio of -11.30 and a beta of 1.08.

Milestone Scientific (NYSE:MLSS) last released its earnings results on Thursday, August 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The business had revenue of $1.85 million for the quarter. Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%.

Insider Buying and Selling

In related news, Director Leonard Osser sold 107,984 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the sale, the director now directly owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last ninety days, insiders sold 251,106 shares of company stock valued at $236,451. 24.75% of the stock is owned by insiders.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.